ConductScience.org, home

Library / Genes

CD59: CD59 molecule (CD59 blood group)

1 protein, 302 patents, 0 drugs, 0 trials, 2,878 NIH grants and 6,419 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolCD59HGNC
NameCD59 molecule (CD59 blood group)HGNC
NCBI Gene ID966NCBI Gene
HGNC IDHGNC:1689HGNC
EnsemblENSG00000085063NCBI Gene
Aliases16.3A5, 1F5, EJ16, EJ30, EL32, G344, HRF-20, HRF20, MAC-IP, MACIF, MEM43, MIC11, MIN1, MIN2, MIN3, MIRL, MSK21, p18-20NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P13987CD59 glycoprotein12817Ensembl, GeneID, HGNCUniProt

Patents 302

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4758256 A12026-06-1741P13987Espacenet
JP 2026515949 A2026-05-196P13987Espacenet
JP 2026053563 A2026-03-254P13987Espacenet
JP 2026004568 A2026-01-1440592P13987Espacenet
JP 2026004568 A2026-01-1440593P13987Espacenet
JP 2026004568 A2026-01-1440594P13987Espacenet
JP 2026004568 A2026-01-1440595P13987Espacenet
JP 2026004568 A2026-01-1440596P13987Espacenet
JP 2026004568 A2026-01-1440597P13987Espacenet
JP 2026004568 A2026-01-1440598P13987Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 2878

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
R01DK076690Complement-mediated injury of the kidney: New mechanisms and novel therapies172,025NIH's project files
P30CA016672Cancer Center Support Grant132,025NIH's project files
P30CA008748Cancer Center Support Grant122,025NIH's project files
P30EY005722Center Core Grant for Vision Research102,025NIH's project files
P01AI045897A Tolerance Approach to Xenotransplantation92,025NIH's project files
R37AI037657Pore Formation by Cholesterol Dependent Cytolysins92,025NIH's project files
T32HL007525Training Program in Hematology82,025NIH's project files
P30CA006973Regional Oncology Research Center72,025NIH's project files
ZIAHL002315Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments72,025NIH's project files
P30ES009089Center for Environmental Health in Northern Manhattan62,025NIH's project files

Papers 6419

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42818647PubTator, text miningPubMed
42810348PubTator, text miningPubMed
42808109PubTator, text miningPubMed
42794833PubTator, text miningPubMed
42782772PubTator, text miningPubMed
42765007PubTator, text miningPubMed
42755219PubTator, text miningPubMed
42746023PubTator, text miningPubMed
42727894PubTator, text miningPubMed
42714081PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license